Illustrative image – not actual.The Foreign Investment Promotion Board (FIPB), on 26 August 2008, approved the acquisition of Ranbaxy by Japan's Daiichi Sankyo. The deal is awaiting clearance from the Finance Minister and the Cabinet Committee on Economic Affairs.
The deal was earlier cleared by the FIPB, but the amount of FDI was miscalculated at Rs.108 crore. Now, after recalculating the amount, it is found to be Rs.21,560 crore. Since the FDI inflow involved in the deal is more than Rs.600 crore, the call on its clearance has to be taken by the CCEA.
